www.natrelle.com Open in urlscan Pro
2606:4700:4400::ac40:9197  Public Scan

Submitted URL: http://gummyimplants.com/
Effective URL: https://www.natrelle.com/
Submission: On November 28 via api from TR — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

✖

See our new privacy terms at https://privacy.abbvie/.

x
For information on BIOCELL® textured breast implants and tissue expanders,
Please click here.
© 2019 Allergan. All rights reserved. All trademarks are the property of their
respective owners.   Natrelle.com  09/19  192805
EXPAND TO SEE ALL ALLERGAN AESTHETICS BRANDS +
 * BOTOX® COSMETIC (ONABOTULINUMTOXINA)
 * SKINVIVE™ by JUVÉDERM
 * JUVÉDERM® COLLECTION OF FILLERS
 * KYBELLA® (DEOXYCHOLIC ACID) INJECTION 10 mg/mL
 * LATISSE® (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%
 * CoolSculpting®
 * SKINMEDICA® SKIN CARE

for surgeons

breast
augmentation
patient
Actual Natrelle INSPIRA® primary augmentation patient. Individual results may
vary.
breast
reconstruction
patient
Actual Natrelle INSPIRA® breast reconstruction patient. Individual results may
vary.
Natrelle® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
SEE MORE +
Natrelle® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The longer people have
them, the greater the chances are that they will develop complications, some of
which will require more surgery.
Breast implants have been associated with the development of a cancer of the
immune system called breast implant–associated anaplastic large cell lymphoma
(BIA-ALCL). This cancer occurs more commonly in patients with textured breast
implants than smooth implants, although rates are not well defined. Some
patients have died from BIA-ALCL.
Patients receiving breast implants have reported a variety of systemic symptoms,
such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune
diseases, and others. Individual patient risk for developing these symptoms has
not been well established. Some patients report complete resolution of symptoms
when the implants are removed without replacement.
Who can get breast implants?
Natrelle® Breast Implants are approved for the following:
 * Breast augmentation for women at least 22 years old for silicone-filled
   implants and for women at least 18 years old for saline-filled implants.
   Breast augmentation includes primary breast augmentation to increase the
   breast size and revision surgery to correct or improve the result of a
   primary breast augmentation
 * Breast reconstruction. This includes primary breast reconstruction to replace
   breast tissue that has been removed due to cancer or trauma or that has
   failed to develop properly due to a severe breast abnormality. This also
   includes revision surgery to correct or improve the result of a primary
   breast reconstruction

Who should NOT get breast implants?
Breast implant surgery should NOT be performed in:
 * Women with active infection anywhere in their body
 * Women with existing cancer or precancer of their breast who have not received
   adequate treatment for those conditions
 * Women who are currently pregnant or nursing

What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as the risks of
breast implant surgery may be higher:
 * Autoimmune diseases (eg, lupus and scleroderma)
 * A weakened immune system (eg, taking medications to decrease the body’s
   immune response)
 * Planned chemotherapy or radiation therapy following breast implant placement
 * Conditions or medications that interfere with wound healing and blood
   clotting
 * Reduced blood supply to breast tissue
 * Clinical diagnosis of depression or other mental health disorders, including
   body dysmorphic disorder and eating disorders
 * Those with a diagnosis of depression or other mental health disorders should
   wait for resolution or stabilization of these conditions prior to undergoing
   breast implantation surgery

What else should I consider?

 * There is a Boxed Warning for breast implants. Please see bold text at
   beginning
 * Many changes to your breasts following implantation are irreversible. If you
   later choose to have your implants removed and not replaced, you may
   experience dimpling, puckering, wrinkling, or other cosmetic changes, which
   may be permanent
 * Breast implantation is likely not a one-time surgery. The longer implants are
   in place, the greater the potential risk for complications. You will likely
   need additional surgeries on your breasts due to complications or
   unacceptable cosmetic results. Thus, you should also consider the
   complication rates for later (revision) surgery since you may experience
   these risks in the future
 * Cancer treatments and surgery will affect the outcome and timing of breast
   reconstruction
 * Breast implants may affect your ability to breastfeed, either by reducing or
   eliminating milk production
 * Rupture of a silicone-filled breast implant is most often silent. Even if you
   have no symptoms, you should have your first ultrasound or MRI at 5 to 6
   years after your initial implant surgery and then every 2 to 3 years
   thereafter regardless of whether your implants are for augmentation or
   reconstruction. If you have symptoms of or uncertain ultrasound results for
   breast implant rupture, an MRI is recommended. Additional imaging may be
   required depending on your medical history and status. The health
   consequences of a ruptured silicone gel-filled breast implant have not been
   fully established
 * Routine screening mammography for breast cancer will be more difficult, and
   implants may rupture during the procedure. Perform self-examination every
   month for cancer screening and ask your surgeon to help you distinguish the
   implant from your breast tissue. Lumps, persistent pain, swelling, hardening,
   or changes in implant shape should be reported to your surgeon and possibly
   evaluated with imaging

What are key complications with breast implants?
Key complications include reoperation, implant removal with or without
replacement, implant rupture with silicone-filled implants, implant deflation
with saline-filled implants, and capsular contracture (severe scar tissue around
the implant). Other complications include breast pain, swelling, asymmetry,
wrinkling/rippling, implant malposition nipple complications, hypertrophic
scarring, and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at rxabbvie.com.
To report a problem with Natrelle® Breast Implants, please call Allergan® at
1-800-624-4261.
The sale and distribution of Natrelle® Breast Implants is restricted to licensed
physicians who provide information to patients about the risks and benefits of
breast implant surgery.

Natrelle® 133S Tissue Expanders Important Information

Approved Uses

Natrelle® 133S Tissue Expanders are approved for breast reconstruction following
mastectomy, treatment of underdeveloped breasts, and treatment of soft tissue
deformities.

IMPORTANT SAFETY INFORMATION
Who should NOT get tissue expanders?
Do not use if you:
 * Already have implanted devices that would be affected by a magnetic field
 * Have tissue unsuitable for expansion
 * Have an active infection or a residual gross tumor at the expansion site
 * Are undergoing adjuvant radiation therapy
 * Have a physiological condition (eg, obesity, smoking, diabetes, autoimmune
   disease, hypertension, chronic lung or severe cardiovascular disease, or
   osteogenesis imperfecta) or use certain drugs (including those that interfere
   with blood clotting or affect tissue viability) that may result in a high
   risk of surgical and/or postoperative complications


What else should I consider?

 * Natrelle® 133S Tissue Expanders should NOT be used in patients who already
   have implanted devices that would be affected by a magnetic field
 * Active infection anywhere may increase risk of infection around the tissue
   expander. Certain infections may require premature removal of the device
 * Natrelle® 133S Tissue Expanders are temporary devices and are not to be used
   for permanent implantation or beyond 6 months. Tissue expansion in breast
   reconstruction typically requires 4 months to 6 months


What are possible complications?


Deflation, tissue damage and/or appearance of the implant through the skin,
infection, unwanted shape, unintended blood or fluid collection, capsular
contracture (tightening of scar tissue that causes the breast to harden),
premature device removal, bone/pain/sensation changes, and inflammation.

For more information, please visit rxabbvie.com. To report a problem with
Natrelle®, please call Allergan at 1-800-624-4261.
Natrelle® 133S Tissue Expanders are available by prescription only. The sale and
distribution of Natrelle® 133S Tissue Expanders is restricted to licensed
physicians.
BOTOX® Cosmetic (onabotulinumtoxinA)
Approved Uses
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and
used to temporarily improve the look of moderate to severe forehead lines,
crow’s feet lines, and frown lines between the eyebrows in adults.
IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get
medical help right away if you have any of these problems any time (hours to
weeks) after injection of BOTOX® Cosmetic:
 * Problems swallowing, speaking, or breathing, due to weakening of associated
   muscles, can be severe and result in loss of life. You are at the highest
   risk if these problems are pre-existing before injection. Swallowing problems
   may last for several months.
 * Spread of toxin effects. The effect of botulinum toxin may affect areas away
   from the injection site and cause serious symptoms including: loss of
   strength and all-over muscle weakness, double vision, blurred vision and
   drooping eyelids, hoarseness or change or loss of voice, trouble saying words
   clearly, loss of bladder control, trouble breathing, and trouble swallowing.

BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other
botulinum toxin product.
There has not been a confirmed serious case of spread of toxin effect when
BOTOX® Cosmetic has been used at the recommended dose to treat frown lines,
crow’s feet lines, and/or forehead lines.
BOTOX® Cosmetic may cause loss of strength or general muscle weakness, vision
problems, or dizziness within hours to weeks of taking BOTOX® Cosmetic. If this
happens, do not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions have been reported. They include:
itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or
feeling faint. Get medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if you: are allergic to any of the ingredients in
BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction
to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB),
Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin
infection at the planned injection site.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou
Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at
increased risk of serious side effects including difficulty swallowing and
difficulty breathing from typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions, including: plans to have
surgery; had surgery on your face; have trouble raising your eyebrows; drooping
eyelids; any other abnormal facial change; are pregnant or plan to become
pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby); are
breast-feeding or plan to (it is not known if BOTOX® Cosmetic passes into breast
milk).
Tell your doctor about all the medicines you take, including prescription and
over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX®
Cosmetic with certain other medicines may cause serious side effects. Do not
start any new medicines until you have told your doctor that you have received
BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin product in the
last 4 months; have received injections of botulinum toxin such as Myobloc®,
Dysport®, or Xeomin® in the past (tell your doctor exactly which product you
received); have recently received an antibiotic by injection; take muscle
relaxants; take an allergy or cold medicine; take a sleep medicine; take
aspirin-like products or blood thinners.
Other side effects of BOTOX® Cosmetic include: dry mouth; discomfort or pain at
the injection site; tiredness; headache; neck pain; and eye problems: double
vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows,
swelling of your eyelids and dry eyes.
For more information refer to the Medication Guide or talk with your doctor.
To report a side effect, please call Allergan at 1-800-678-1605.

Please see BOTOX® Cosmetic full Product Information including Boxed Warning and
Medication Guide.
JUVÉDERM® Injectable Gel Fillers Important Information
APPROVED USES
JUVÉDERM® VOLUX® XC injectable gel is for deep injection to improve moderate to
severe loss of jawline definition in adults over the age of 21.
JUVÉDERM® VOLUMA® XC injectable gel is for deep injection in the cheek area to
correct age-related volume loss and for augmentation of the chin region to
improve the chin profile in adults over 21.
JUVÉDERM® VOLLURE® XC, JUVÉDERM® Ultra Plus XC, and JUVÉDERM® Ultra XC
injectable gels are for injection into the facial tissue for the correction of
moderate to severe facial wrinkles and folds, such as nasolabial folds.
JUVÉDERM® VOLLURE® XC injectable gel is for adults over 21.
JUVÉDERM® Ultra XC injectable gel is also for injection into the lips and
perioral area for lip augmentation in adults over 21.
JUVÉDERM® VOLBELLA® XC injectable gel is for injection into the lips for lip
augmentation and correction of perioral lines, and for injection into the
undereye hollows to improve the appearance of undereye hollows in adults over
the age of 21.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive any JUVÉDERM® formulation?

Do not use these products if you have a history of multiple severe allergies or
severe allergic reactions (anaphylaxis), if you are allergic to lidocaine or the
Gram-positive bacterial proteins used in these products, or if you have had
previous allergic reactions to hyaluronic acid fillers.

What warnings should my doctor advise me about?
 * One of the risks with using dermal fillers is the unintentional injection
   into a blood vessel. The chances of this happening are very small, but if it
   does happen, the complications can be serious and may be permanent. These
   complications, which have been reported for facial injections, can include
   vision abnormalities, blindness, stroke, temporary scabs, or permanent
   scarring of the skin. Most of these events are irreversible.
 * If you have changes in your vision, signs of a stroke (including sudden
   difficulty speaking, numbness or weakness in your face, arms or legs,
   difficulty walking, face drooping, severe headache, dizziness, or confusion),
   white appearance of the skin, or unusual pain during or shortly after
   treatment, you should notify your health care practitioner immediately.
 * The use of dermal fillers where skin sores, pimples, rashes, hives, cysts, or
   infections are present should be postponed, as this may delay healing or make
   skin problems worse.
 * The effectiveness of removal of any dermal filler has not been studied.

What precautions should my doctor advise me about?
 * JUVÉDERM® VOLBELLA® XC should only be injected into undereye hollows by
   doctors who have completed the necessary training for this treatment area. To
   find a doctor, visit Juvederm.com/find-a-specialist. Doctors who complete the
   training will be listed with a symbol
 * The safety of these products for use during pregnancy or while breastfeeding
   has not been studied
 * The safety of JUVÉDERM® VOLUMA® XC has not been studied in patients under 35
   years or over 65 years for cheek augmentation, or under 22 years and over 80
   years for chin augmentation. The safety of JUVÉDERM® VOLUX® XC, JUVÉDERM®
   VOLLURE® XC and JUVÉDERM® VOLBELLA® XC has not been studied in patients under
   22 years, and the safety of JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC
   has not been studied in patients under 18 years
 * The safety and effectiveness of treatment with JUVÉDERM® products in
   anatomical regions outside of their approved uses have not been established
   in clinical studies
 * If you have a history of excessive scarring (thick, hard scars) or
   pigmentation disorders, treatment in these patients has not been studied and
   may result in additional scars or changes in pigmentation
 * If you are planning other procedures including laser treatments or a chemical
   peel, there is a possible risk of inflammation at the treatment site if these
   procedures are performed closely before or after JUVÉDERM® injectable gel
   treatment
 * Tell your doctor if you are on therapy used to reduce your body’s natural
   defense system (such as steroids, chemotherapy, and medicines to treat
   autoimmune diseases, HIV, and AIDs), as these may increase your risk of
   infection; and medications that can prolong bleeding (such as aspirin,
   ibuprofen, or other blood thinners), as these may result in increased
   bruising or bleeding at the injection site.
 * Avoid applying makeup for 12 hours after treatment and minimize strenuous
   exercise, exposure to extensive sun or heat, and alcoholic beverages within
   the first 24 hours following treatment, as these may cause temporary redness,
   swelling, and/or itching at the injection site
 * JUVÉDERM® VOLUMA® XC was not studied in patients with significant loose skin
   of the chin, neck, or jaw
 * The effect of JUVÉDERM® VOLUMA® XC injection into the chin on facial hair
   growth has not been studied
 * Patients who experience skin injury near the site of JUVÉDERM® VOLUMA® XC
   injection may be at a higher risk for adverse events
 * Tell your doctor if you have already been injected with dermal fillers in the
   same area as the one(s) you are about to be treated for. This information
   helps your doctor decide when and whether you should get treatment

What are possible side effects of treatment?

The most commonly reported side effects with JUVÉDERM® injectable gels were
redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising,
discoloration, and itching. For JUVÉDERM® VOLBELLA® XC, dryness was also
reported.

These side effects are consistent with other facial injection procedures and
most will resolve within 30 days. Your doctor may choose to treat side effects
persisting longer with antibiotics, steroids, or hyaluronidase (an enzyme that
breaks down hyaluronic acid).
As with all skin injection procedures, there is a risk of infection.
To report a side effect with any product in the JUVÉDERM® Collection, please
call the Allergan® Product Support Department at 1-877-345-5372. Please also
visit Juvederm.com or talk to your doctor for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician
or properly licensed practitioner.
Natrelle Perks℠ Terms and Conditions
 * Allē Members who undergo breast augmentation with Natrelle® gel implants
   (“Member”) may qualify to receive either (a) one (1) complimentary treatment
   of BOTOX® Cosmetic (onabotulinumtoxinA) up to 50 units OR (b) one (1)
   complimentary treatment of JUVÉDERM® Ultra XC up to two .55 mL syringes at
   participating Allē provider offices only. Allergan Aesthetics is not
   responsible for any associated injection costs.
 * Members enrolled in Medicare, Medicaid, or other federal or state healthcare
   programs are not eligible for this offer.
 * Member must claim offer in the Allē app via text message link within 6 months
   of their Natrelle® breast augmentation and select their complimentary
   treatment.
 * Once claimed, the selected complimentary treatment cannot be changed and the
   offer must be redeemed within 6 months of the offer being deposited into
   Member’s Allē Wallet. Offer expires 6 months after issue date into Allē
   Wallet.
 * Limit 1 per Member.
 * A healthcare provider will determine if Member is an appropriate candidate
   for a BOTOX® Cosmetic or JUVÉDERM® Ultra XC treatment.
   * If Member is an appropriate candidate, offer can be redeemed at a
     participating provider’s office.
 * Standard Allē Loyalty Program Terms and Conditions apply.
 * Members will earn Allē points on all qualifying Earnings Eligible Product
   purchases, subject to applicable earnings caps.
 * The value of this offer cannot be redeemed or exchanged for cash.
 * Offer cannot be applied to past transactions.
 * Offer cannot be combined with other Allē offers on BOTOX® Cosmetic or the
   JUVÉDERM® Collection of Fillers but can be combined with Allē and Allē
   brand-specific gift cards, Allē points offers, including Double Points
   offers, and other Allē brand-specific offers.
 * The complete value of this offer must be used in a single transaction.
 * If you have questions, please contact Allē Customer Support at 1-888-912-1572
   Monday - Friday, 8 am – 6 pm CT.
 * Allergan Aesthetics, an AbbVie company, reserves the right to alter or cancel
   this offer at any time.

Back to top
Natrelle® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
SEE MORE +
Natrelle® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The longer people have
them, the greater the chances are that they will develop complications, some of
which will require more surgery.
Breast implants have been associated with the development of a cancer of the
immune system called breast implant–associated anaplastic large cell lymphoma
(BIA-ALCL). This cancer occurs more commonly in patients with textured breast
implants than smooth implants, although rates are not well defined. Some
patients have died from BIA-ALCL.
Patients receiving breast implants have reported a variety of systemic symptoms,
such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune
diseases, and others. Individual patient risk for developing these symptoms has
not been well established. Some patients report complete resolution of symptoms
when the implants are removed without replacement.
Who can get breast implants?
Natrelle® Breast Implants are approved for the following:
 * Breast augmentation for women at least 22 years old for silicone-filled
   implants and for women at least 18 years old for saline-filled implants.
   Breast augmentation includes primary breast augmentation to increase the
   breast size and revision surgery to correct or improve the result of a
   primary breast augmentation
 * Breast reconstruction. This includes primary breast reconstruction to replace
   breast tissue that has been removed due to cancer or trauma or that has
   failed to develop properly due to a severe breast abnormality. This also
   includes revision surgery to correct or improve the result of a primary
   breast reconstruction

Who should NOT get breast implants?
Breast implant surgery should NOT be performed in:
 * Women with active infection anywhere in their body
 * Women with existing cancer or precancer of their breast who have not received
   adequate treatment for those conditions
 * Women who are currently pregnant or nursing

What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as the risks of
breast implant surgery may be higher:
 * Autoimmune diseases (eg, lupus and scleroderma)
 * A weakened immune system (eg, taking medications to decrease the body’s
   immune response)
 * Planned chemotherapy or radiation therapy following breast implant placement
 * Conditions or medications that interfere with wound healing and blood
   clotting
 * Reduced blood supply to breast tissue
 * Clinical diagnosis of depression or other mental health disorders, including
   body dysmorphic disorder and eating disorders
 * Those with a diagnosis of depression or other mental health disorders should
   wait for resolution or stabilization of these conditions prior to undergoing
   breast implantation surgery

What else should I consider?

 * There is a Boxed Warning for breast implants. Please see bold text at
   beginning
 * Many changes to your breasts following implantation are irreversible. If you
   later choose to have your implants removed and not replaced, you may
   experience dimpling, puckering, wrinkling, or other cosmetic changes, which
   may be permanent
 * Breast implantation is likely not a one-time surgery. The longer implants are
   in place, the greater the potential risk for complications. You will likely
   need additional surgeries on your breasts due to complications or
   unacceptable cosmetic results. Thus, you should also consider the
   complication rates for later (revision) surgery since you may experience
   these risks in the future
 * Cancer treatments and surgery will affect the outcome and timing of breast
   reconstruction
 * Breast implants may affect your ability to breastfeed, either by reducing or
   eliminating milk production
 * Rupture of a silicone-filled breast implant is most often silent. Even if you
   have no symptoms, you should have your first ultrasound or MRI at 5 to 6
   years after your initial implant surgery and then every 2 to 3 years
   thereafter regardless of whether your implants are for augmentation or
   reconstruction. If you have symptoms of or uncertain ultrasound results for
   breast implant rupture, an MRI is recommended. Additional imaging may be
   required depending on your medical history and status. The health
   consequences of a ruptured silicone gel-filled breast implant have not been
   fully established
 * Routine screening mammography for breast cancer will be more difficult, and
   implants may rupture during the procedure. Perform self-examination every
   month for cancer screening and ask your surgeon to help you distinguish the
   implant from your breast tissue. Lumps, persistent pain, swelling, hardening,
   or changes in implant shape should be reported to your surgeon and possibly
   evaluated with imaging

What are key complications with breast implants?
Key complications include reoperation, implant removal with or without
replacement, implant rupture with silicone-filled implants, implant deflation
with saline-filled implants, and capsular contracture (severe scar tissue around
the implant). Other complications include breast pain, swelling, asymmetry,
wrinkling/rippling, implant malposition nipple complications, hypertrophic
scarring, and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at rxabbvie.com.
To report a problem with Natrelle® Breast Implants, please call Allergan® at
1-800-624-4261.
The sale and distribution of Natrelle® Breast Implants is restricted to licensed
physicians who provide information to patients about the risks and benefits of
breast implant surgery.

Natrelle® 133S Tissue Expanders Important Information

Approved Uses

Natrelle® 133S Tissue Expanders are approved for breast reconstruction following
mastectomy, treatment of underdeveloped breasts, and treatment of soft tissue
deformities.

IMPORTANT SAFETY INFORMATION
Who should NOT get tissue expanders?
Do not use if you:
 * Already have implanted devices that would be affected by a magnetic field
 * Have tissue unsuitable for expansion
 * Have an active infection or a residual gross tumor at the expansion site
 * Are undergoing adjuvant radiation therapy
 * Have a physiological condition (eg, obesity, smoking, diabetes, autoimmune
   disease, hypertension, chronic lung or severe cardiovascular disease, or
   osteogenesis imperfecta) or use certain drugs (including those that interfere
   with blood clotting or affect tissue viability) that may result in a high
   risk of surgical and/or postoperative complications


What else should I consider?

 * Natrelle® 133S Tissue Expanders should NOT be used in patients who already
   have implanted devices that would be affected by a magnetic field
 * Active infection anywhere may increase risk of infection around the tissue
   expander. Certain infections may require premature removal of the device
 * Natrelle® 133S Tissue Expanders are temporary devices and are not to be used
   for permanent implantation or beyond 6 months. Tissue expansion in breast
   reconstruction typically requires 4 months to 6 months


What are possible complications?


Deflation, tissue damage and/or appearance of the implant through the skin,
infection, unwanted shape, unintended blood or fluid collection, capsular
contracture (tightening of scar tissue that causes the breast to harden),
premature device removal, bone/pain/sensation changes, and inflammation.

For more information, please visit rxabbvie.com. To report a problem with
Natrelle®, please call Allergan at 1-800-624-4261.
Natrelle® 133S Tissue Expanders are available by prescription only. The sale and
distribution of Natrelle® 133S Tissue Expanders is restricted to licensed
physicians.
BOTOX® Cosmetic (onabotulinumtoxinA)
Approved Uses
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and
used to temporarily improve the look of moderate to severe forehead lines,
crow’s feet lines, and frown lines between the eyebrows in adults.
IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get
medical help right away if you have any of these problems any time (hours to
weeks) after injection of BOTOX® Cosmetic:
 * Problems swallowing, speaking, or breathing, due to weakening of associated
   muscles, can be severe and result in loss of life. You are at the highest
   risk if these problems are pre-existing before injection. Swallowing problems
   may last for several months.
 * Spread of toxin effects. The effect of botulinum toxin may affect areas away
   from the injection site and cause serious symptoms including: loss of
   strength and all-over muscle weakness, double vision, blurred vision and
   drooping eyelids, hoarseness or change or loss of voice, trouble saying words
   clearly, loss of bladder control, trouble breathing, and trouble swallowing.

BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other
botulinum toxin product.
There has not been a confirmed serious case of spread of toxin effect when
BOTOX® Cosmetic has been used at the recommended dose to treat frown lines,
crow’s feet lines, and/or forehead lines.
BOTOX® Cosmetic may cause loss of strength or general muscle weakness, vision
problems, or dizziness within hours to weeks of taking BOTOX® Cosmetic. If this
happens, do not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions have been reported. They include:
itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or
feeling faint. Get medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if you: are allergic to any of the ingredients in
BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction
to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB),
Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin
infection at the planned injection site.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou
Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at
increased risk of serious side effects including difficulty swallowing and
difficulty breathing from typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions, including: plans to have
surgery; had surgery on your face; have trouble raising your eyebrows; drooping
eyelids; any other abnormal facial change; are pregnant or plan to become
pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby); are
breast-feeding or plan to (it is not known if BOTOX® Cosmetic passes into breast
milk).
Tell your doctor about all the medicines you take, including prescription and
over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX®
Cosmetic with certain other medicines may cause serious side effects. Do not
start any new medicines until you have told your doctor that you have received
BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin product in the
last 4 months; have received injections of botulinum toxin such as Myobloc®,
Dysport®, or Xeomin® in the past (tell your doctor exactly which product you
received); have recently received an antibiotic by injection; take muscle
relaxants; take an allergy or cold medicine; take a sleep medicine; take
aspirin-like products or blood thinners.
Other side effects of BOTOX® Cosmetic include: dry mouth; discomfort or pain at
the injection site; tiredness; headache; neck pain; and eye problems: double
vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows,
swelling of your eyelids and dry eyes.
For more information refer to the Medication Guide or talk with your doctor.
To report a side effect, please call Allergan at 1-800-678-1605.

Please see BOTOX® Cosmetic full Product Information including Boxed Warning and
Medication Guide.
JUVÉDERM® Injectable Gel Fillers Important Information
APPROVED USES
JUVÉDERM® VOLUX® XC injectable gel is for deep injection to improve moderate to
severe loss of jawline definition in adults over the age of 21.
JUVÉDERM® VOLUMA® XC injectable gel is for deep injection in the cheek area to
correct age-related volume loss and for augmentation of the chin region to
improve the chin profile in adults over 21.
JUVÉDERM® VOLLURE® XC, JUVÉDERM® Ultra Plus XC, and JUVÉDERM® Ultra XC
injectable gels are for injection into the facial tissue for the correction of
moderate to severe facial wrinkles and folds, such as nasolabial folds.
JUVÉDERM® VOLLURE® XC injectable gel is for adults over 21.
JUVÉDERM® Ultra XC injectable gel is also for injection into the lips and
perioral area for lip augmentation in adults over 21.
JUVÉDERM® VOLBELLA® XC injectable gel is for injection into the lips for lip
augmentation and correction of perioral lines, and for injection into the
undereye hollows to improve the appearance of undereye hollows in adults over
the age of 21.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive any JUVÉDERM® formulation?

Do not use these products if you have a history of multiple severe allergies or
severe allergic reactions (anaphylaxis), if you are allergic to lidocaine or the
Gram-positive bacterial proteins used in these products, or if you have had
previous allergic reactions to hyaluronic acid fillers.

What warnings should my doctor advise me about?
 * One of the risks with using dermal fillers is the unintentional injection
   into a blood vessel. The chances of this happening are very small, but if it
   does happen, the complications can be serious and may be permanent. These
   complications, which have been reported for facial injections, can include
   vision abnormalities, blindness, stroke, temporary scabs, or permanent
   scarring of the skin. Most of these events are irreversible.
 * If you have changes in your vision, signs of a stroke (including sudden
   difficulty speaking, numbness or weakness in your face, arms or legs,
   difficulty walking, face drooping, severe headache, dizziness, or confusion),
   white appearance of the skin, or unusual pain during or shortly after
   treatment, you should notify your health care practitioner immediately.
 * The use of dermal fillers where skin sores, pimples, rashes, hives, cysts, or
   infections are present should be postponed, as this may delay healing or make
   skin problems worse.
 * The effectiveness of removal of any dermal filler has not been studied.

What precautions should my doctor advise me about?
 * JUVÉDERM® VOLBELLA® XC should only be injected into undereye hollows by
   doctors who have completed the necessary training for this treatment area. To
   find a doctor, visit Juvederm.com/find-a-specialist. Doctors who complete the
   training will be listed with a symbol
 * The safety of these products for use during pregnancy or while breastfeeding
   has not been studied
 * The safety of JUVÉDERM® VOLUMA® XC has not been studied in patients under 35
   years or over 65 years for cheek augmentation, or under 22 years and over 80
   years for chin augmentation. The safety of JUVÉDERM® VOLUX® XC, JUVÉDERM®
   VOLLURE® XC and JUVÉDERM® VOLBELLA® XC has not been studied in patients under
   22 years, and the safety of JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC
   has not been studied in patients under 18 years
 * The safety and effectiveness of treatment with JUVÉDERM® products in
   anatomical regions outside of their approved uses have not been established
   in clinical studies
 * If you have a history of excessive scarring (thick, hard scars) or
   pigmentation disorders, treatment in these patients has not been studied and
   may result in additional scars or changes in pigmentation
 * If you are planning other procedures including laser treatments or a chemical
   peel, there is a possible risk of inflammation at the treatment site if these
   procedures are performed closely before or after JUVÉDERM® injectable gel
   treatment
 * Tell your doctor if you are on therapy used to reduce your body’s natural
   defense system (such as steroids, chemotherapy, and medicines to treat
   autoimmune diseases, HIV, and AIDs), as these may increase your risk of
   infection; and medications that can prolong bleeding (such as aspirin,
   ibuprofen, or other blood thinners), as these may result in increased
   bruising or bleeding at the injection site.
 * Avoid applying makeup for 12 hours after treatment and minimize strenuous
   exercise, exposure to extensive sun or heat, and alcoholic beverages within
   the first 24 hours following treatment, as these may cause temporary redness,
   swelling, and/or itching at the injection site
 * JUVÉDERM® VOLUMA® XC was not studied in patients with significant loose skin
   of the chin, neck, or jaw
 * The effect of JUVÉDERM® VOLUMA® XC injection into the chin on facial hair
   growth has not been studied
 * Patients who experience skin injury near the site of JUVÉDERM® VOLUMA® XC
   injection may be at a higher risk for adverse events
 * Tell your doctor if you have already been injected with dermal fillers in the
   same area as the one(s) you are about to be treated for. This information
   helps your doctor decide when and whether you should get treatment

What are possible side effects of treatment?

The most commonly reported side effects with JUVÉDERM® injectable gels were
redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising,
discoloration, and itching. For JUVÉDERM® VOLBELLA® XC, dryness was also
reported.

These side effects are consistent with other facial injection procedures and
most will resolve within 30 days. Your doctor may choose to treat side effects
persisting longer with antibiotics, steroids, or hyaluronidase (an enzyme that
breaks down hyaluronic acid).
As with all skin injection procedures, there is a risk of infection.
To report a side effect with any product in the JUVÉDERM® Collection, please
call the Allergan® Product Support Department at 1-877-345-5372. Please also
visit Juvederm.com or talk to your doctor for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician
or properly licensed practitioner.
Natrelle Perks℠ Terms and Conditions
 * Allē Members who undergo breast augmentation with Natrelle® gel implants
   (“Member”) may qualify to receive either (a) one (1) complimentary treatment
   of BOTOX® Cosmetic (onabotulinumtoxinA) up to 50 units OR (b) one (1)
   complimentary treatment of JUVÉDERM® Ultra XC up to two .55 mL syringes at
   participating Allē provider offices only. Allergan Aesthetics is not
   responsible for any associated injection costs.
 * Members enrolled in Medicare, Medicaid, or other federal or state healthcare
   programs are not eligible for this offer.
 * Member must claim offer in the Allē app via text message link within 6 months
   of their Natrelle® breast augmentation and select their complimentary
   treatment.
 * Once claimed, the selected complimentary treatment cannot be changed and the
   offer must be redeemed within 6 months of the offer being deposited into
   Member’s Allē Wallet. Offer expires 6 months after issue date into Allē
   Wallet.
 * Limit 1 per Member.
 * A healthcare provider will determine if Member is an appropriate candidate
   for a BOTOX® Cosmetic or JUVÉDERM® Ultra XC treatment.
   * If Member is an appropriate candidate, offer can be redeemed at a
     participating provider’s office.
 * Standard Allē Loyalty Program Terms and Conditions apply.
 * Members will earn Allē points on all qualifying Earnings Eligible Product
   purchases, subject to applicable earnings caps.
 * The value of this offer cannot be redeemed or exchanged for cash.
 * Offer cannot be applied to past transactions.
 * Offer cannot be combined with other Allē offers on BOTOX® Cosmetic or the
   JUVÉDERM® Collection of Fillers but can be combined with Allē and Allē
   brand-specific gift cards, Allē points offers, including Double Points
   offers, and other Allē brand-specific offers.
 * The complete value of this offer must be used in a single transaction.
 * If you have questions, please contact Allē Customer Support at 1-888-912-1572
   Monday - Friday, 8 am – 6 pm CT.
 * Allergan Aesthetics, an AbbVie company, reserves the right to alter or cancel
   this offer at any time.

Back to top
PRIVACY STATEMENT TERMS OF USE
FIND A SURGEON CONTACT US Cookies Settings
© 2023 AbbVie. All rights reserved.
JUVÉDERM and its design are trademarks of Allergan Holdings France SAS, an
AbbVie company, or its affiliates.
NATRELLE and its design are trademarks of Allergan Inc., an AbbVie company.
All other trademarks are the property of their respective owners.
Natrelle.com  MBD104055-v19  05/23   022236



This site uses cookies to personalize content, save your preferences, provide
social media features, enable personalized advertising and track the site's
performance as described in our Privacy Notice. Please review your Cookie
Settings to confirm your choices before continuing to browse this site. You can
make changes at any time by accessing the Cookie Settings link in the footer of
this site.

Cookies Settings
Close


PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience.

You can choose not to allow some types of cookies. Click on the different
category headings to find out more and change our default settings. However,
blocking some types of cookies may impact your experience of the site and the
services we are able to offer.
More information
Allow All


MANAGE COOKIE SETTINGS

REQUIRED COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They may be set by us or by third party providers whose
services we have added to our pages. They are usually only set in response to
actions made by you which amount to a request for services, such as setting your
privacy or language preferences, logging in or filling in forms. You can set
your browser to block or alert you about these cookies, but some parts of the
site will not work.

View Vendor Details‎

FUNCTIONAL COOKIES

Always Active

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.
If you do not allow these cookies we will not be able to monitor our site’s
performance or learn how to make it better but the site will still work.

View Vendor Details‎

ADVERTISING COOKIES

Advertising Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

View Vendor Details‎
Back Button


PERFORMANCE COOKIES



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

 * 
   
   View Cookies
   
    * Name
      cookie name

Confirm My Choices